US2009286983A1PendingUtilityA1

Pyrazolopyridine Derivates

60
Assignee: PALAU PHARMA SAPriority: Feb 27, 2003Filed: Jul 29, 2009Published: Nov 19, 2009
Est. expiryFeb 27, 2023(expired)· nominal 20-yr term from priority
Inventors:Carmen Almansa RosalesMarina Virgili Bernado
A61P 37/00A61P 43/00A61P 37/02A61P 9/00A61P 9/10A61P 31/00A61P 35/02A61P 25/28A61P 29/00A61P 35/00A61P 19/08C07D 471/04A61K 31/437
60
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

New compounds of formula (I) and the salts thereof, wherein the meanings for the various substituents are as disclosed in the description, are useful as p38 kinase inhibitors.

Claims

exact text as granted — not AI-modified
1 . A compound selected from
 2-ethyl-4,6-bis(4-fluorophenyl)-5-(4-pyridyl)pyrazolo[3,4-b]pyridine.   4,6-bis(4-fluorophenyl)-2-methyl-5-(4-pyridyl)pyrazolo[3,4-b]pyridine.   3-[4,6-bis(4-fluorophenyl)-5-(4-pyridyl)pyrazolo[3,4-b]pyridin-2-yl]propan-1-ol.   4,6-bis(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)pyrazolo[3,4-b]pyridine.   N-methyl-[3-[4,6-bis(4-fluorophenyl)-5-(4-pyridyl)-pyrazolo[3,4-b]pyridin-2-yl]propyl]amine.   2-[4,6-bis(4-fluorophenyl)-5-(4-pyridyl)pyrazolo[3,4-b]pyridin-2-yl]ethanol.   1-[2-[4,6-bis(4-fluorophenyl)-5-(4-pyridyl)pyrazolo[3,4-b]pyridin-2-yl]ethyl]piperidin-4-ol.   3-[4,6-bis(4-fluorophenyl)-5-(4-pyridyl)pyrazolo[3,4-b]pyridin-2-yl]-2-hydroxypropan-1-ol.   [1-[2-[4,6-bis(4-fluorophenyl)-5-(4-pyridyl)pyrazolo[3,4-b]pyridin-2-yl]ethyl]piperidin-4-yl]amine.   4,6-bis(4-fluorophenyl)-5-(4-pyridyl)-2-vinylpyrazolo[3,4-b]pyridine.   
   
   
       2 . A compound according to  claim 1  which is 2-ethyl-4,6-bis(4-fluorophenyl)-5-(4-pyridyl)pyrazolo[3,4-b]pyridine. 
   
   
       3 . A compound according to  claim 1  which is 4,6-bis(4-fluorophenyl)-2-methyl-5-(4-pyridyl)pyrazolo[3,4-b]pyridine. 
   
   
       4 . A compound according to  claim 1  which is 3-[4,6-bis(4-fluorophenyl)-5-(4-pyridyl)pyrazolo[3,4-b]pyridin-2-yl]propan-1-ol. 
   
   
       5 . A compound according to  claim 1  which is 4,6-bis(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)pyrazolo[3,4-b]pyridine. 
   
   
       6 . A compound according to  claim 1  which is N-methyl-[3-[4,6-bis(4-fluorophenyl)-5-(4-pyridyl)-pyrazolo[3,4-b]pyridin-2-yl]propyl]amine. 
   
   
       7 . A compound according to  claim 1  which is 2-[4,6-bis(4-fluorophenyl)-5-(4-pyridyl)pyrazolo[3,4-b]pyridin-2-yl]ethanol. 
   
   
       8 . A compound according to  claim 1  which is 1-[2-[4,6-bis(4-fluorophenyl)-5-(4-pyridyl)pyrazolo[3,4-b]pyridin-2-yl]ethyl]piperidin-4-ol. 
   
   
       9 . A compound according to  claim 1  which is 3-[4,6-bis(4-fluorophenyl)-5-(4-pyridyl)pyrazolo[3,4-b]pyridin-2-yl]-2-hydroxypropan-1-ol. 
   
   
       10 . A compound according to  claim 1  which is [1-[2-[4,6-bis(4-fluorophenyl)-5-(4-pyridyl)pyrazolo[3,4-b]pyridin-2-yl]ethyl]piperidin-4-yl]amine. 
   
   
       11 . A compound according to  claim 1  which is 4,6-bis(4-fluorophenyl)-5-(4-pyridyl)-2-vinylpyrazolo[3,4-b]pyridine.

Join the waitlist — get patent alerts

Track US2009286983A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.